Notable recent developments include the first preclinical study demonstrating NNMT inhibition improves cardiac function and reduces fibrosis in a heart failure model (Li et al., 2025), a comprehensive review of NNMT as a therapeutic target for neurodegenerative disorders (Liu et al., 2025), and emerging evidence that NNMT inhibition counteracts tubular senescence and fibrosis in chronic kidney disease
This leads to a lower red blood cell count and iron deficiency
Cutting edge: nucleocapsid vaccine elicits spike-independent SARS-CoV-2 protective immunity
Key Medical Coding Tips: Use clear, concise language : Note symptoms and lab orders Include test results : Hemoglobin levels, hematocrit, etc
Start at 0.51 mg and climb only if needed
Yes , Wegovy has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) for the long-term treatment of obesity and can be used for as long as it remains beneficial